Abstract
Antiplatelet therapy plays an important role in the management of atherosclerotic disease and numerous studies have shown their efficacy in the reduction of cardiovascular mortality and morbidity. Antiplatelets are given in patients subjected to lower limb bypass aiming not only to reduce cardiovascular mortality and morbidity but also improve graft patency. Various antiplatelet agents have been used for this purpose. The aim of this review article is to critically evaluate the existing evidence on the impact of antiplatelet therapy for maintaining infrainguinal graft patency and highlight the mechanisms involved along these lines.
Keywords: Antiplatelet agents, peripheral arterial disease, infrainguinal bypass, graft patency, aspirin, clopidogrel, ticlopidine, ticlopidine, Lower limb atherosclerosis, femoropopliteal
Current Vascular Pharmacology
Title:A Critical Analysis on the Impact of Antiplatelet Therapy in the Patency of Infrainguinal Bypass Grafts
Volume: 11 Issue: 1
Author(s): George S. Sfyroeras, Vassileios Saleptsis, Christos Argyriou, Georgios A. Antoniou, Frans L. Moll and Athanasios D. Giannoukas
Affiliation:
Keywords: Antiplatelet agents, peripheral arterial disease, infrainguinal bypass, graft patency, aspirin, clopidogrel, ticlopidine, ticlopidine, Lower limb atherosclerosis, femoropopliteal
Abstract: Antiplatelet therapy plays an important role in the management of atherosclerotic disease and numerous studies have shown their efficacy in the reduction of cardiovascular mortality and morbidity. Antiplatelets are given in patients subjected to lower limb bypass aiming not only to reduce cardiovascular mortality and morbidity but also improve graft patency. Various antiplatelet agents have been used for this purpose. The aim of this review article is to critically evaluate the existing evidence on the impact of antiplatelet therapy for maintaining infrainguinal graft patency and highlight the mechanisms involved along these lines.
Export Options
About this article
Cite this article as:
S. Sfyroeras George, Saleptsis Vassileios, Argyriou Christos, A. Antoniou Georgios, L. Moll Frans and D. Giannoukas Athanasios, A Critical Analysis on the Impact of Antiplatelet Therapy in the Patency of Infrainguinal Bypass Grafts, Current Vascular Pharmacology 2013; 11 (1) . https://dx.doi.org/10.2174/1570161111309010047
DOI https://dx.doi.org/10.2174/1570161111309010047 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mesoionic Oxatriazoles (MOTA): NO-Donating Characteristics and Pharmacology
Current Pharmaceutical Design Current Status of Rho-Associated Kinases (ROCKs) in Coronary Atherosclerosis and Vasospasm
Cardiovascular & Hematological Agents in Medicinal Chemistry Neuropilin Signalling in Vascular Development and Pathology
Current Angiogenesis (Discontinued) CD93 and Related Family Members: Their Role in Innate Immunity
Current Drug Targets Stent Selection in Patients with Myocardial Infarction: Drug Eluting, Biodegradable Polymers or Bare Metal Stents?
Recent Patents on Cardiovascular Drug Discovery 5-Adenosine Monophosphate-Activated Protein Kinase and the Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Effect of Antenatal Steroids on Haemodynamics in the Normally Grown and Growth Restricted Fetus
Current Pediatric Reviews Editorial [Hot Topic: IgG4-Related Disease: A Unique and Emerging Entity (Guest Editors: Susumu Sugai, Shigeyuki Kawa, Yoh Zen)]
Current Immunology Reviews (Discontinued) Chemokines and Brain Functions
Current Drug Targets - Inflammation & Allergy Role of miRNAs in Coronary Artery Disease
Current Signal Transduction Therapy Management of Early Stage Cervical Cancer
Reviews on Recent Clinical Trials Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk
Current Pharmaceutical Design Epigenetics in Vascular Disease – Therapeutic Potential of New Agents
Current Vascular Pharmacology Adrenomedullin Expression in Alzheimer's Brain
Current Alzheimer Research Functions of S100 Proteins
Current Molecular Medicine Assessment and Relevance of Carotid Intima-Media Thickness (C-IMT) in Primary and Secondary Cardiovascular Prevention
Current Pharmaceutical Design The Role of microRNAs in the Development of Type 2 Diabetes Complications
Current Pharmaceutical Design Virgin Olive Oil and Hypertension
Current Vascular Pharmacology Meet Our Editorial Board Member
Current Gene Therapy Experimental Antioxidant Biotherapy for Protection of the Vascular Wall by Modified Forms of Superoxide Dismutase and Catalase
Current Pharmaceutical Design